Literature DB >> 8917237

Multivariable predictive models for adverse outcome of invasive meningococcal disease in children.

R Malley1, W C Huskins, N Kuppermann.   

Abstract

For prediction of adverse outcome (AO, defined as death or limb amputation) of invasive meningococcal disease (IMD) in children, two multivariable models were derived and validated by reviewing the data in the medical records of patients with IMD, who ranged from birth to 19 years of age, at three pediatric referral hospitals between 1985 and 1990 (derivation set, n = 153, 19 AO) and between 1991 and 1994 (validation set, n = 92, 11 AO). Variables in the derivation set significantly associated with AO (p < 0.05) were entered into a logistic regression analysis. Because coagulation studies (prothrombin time, partial thromboplastin time, and serum fibrinogen concentration) were available for only 50% of patients, two analyses were performed, either excluding (model 1) or including (model 2) coagulation studies. These analyses identified an absolute neutrophil count less than 3000/mm3, poor perfusion, and a platelet count less than 150,000/mm3 (model 1), and a serum fibrinogen concentration less than 2.5 gm/L (250 mg/dl) and an absolute neutrophil count less than 3000/mm3 (model 2), as independent predictors of AO (p < 0.05). When the models were tested on the validation set, the presence of at least two of the three predictors in model 1 had a sensitivity of 82% and a specificity of 97% in predicting AO; the presence of both predictors in model 2 had a sensitivity of 89% and a specificity of 97%. These models can reliably identify patients with IMD at high risk of AO for whom consideration of novel therapies is justified.

Entities:  

Mesh:

Year:  1996        PMID: 8917237     DOI: 10.1016/s0022-3476(96)70153-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

1.  A new prognostic scoring system for meningococcal septic shock in children: comparison with three other scoring systems.

Authors:  Nathan Kuppermann; Richard Malley; W Charles Huskins
Journal:  Intensive Care Med       Date:  2002-12-14       Impact factor: 17.440

Review 2.  Recognition, treatment and complications of meningococcal disease.

Authors:  F A Riordan; A P Thomson
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.022

3.  [Foudroyant meningococcal sepsis in emergency medicine. Medical treatment and post-exposure prophylaxis].

Authors:  C H R Wiese; M Roessler; U Bartels; M Quintel; B M Graf
Journal:  Anaesthesist       Date:  2008-04       Impact factor: 1.041

4.  Invasive meningococcal disease in children in Greece: comparison of serogroup A disease with disease caused by other serogroups.

Authors:  M N Tsolia; M Theodoridou; G Tzanakaki; V Vlachou; G Mostrou; F Stripeli; P Kalabalikis; A Pangalis; D Kafetzis; J Kremastinou; A Konstantopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-07       Impact factor: 3.267

5.  Neurodevelopmental outcome in meningococcal disease: a case-control study.

Authors:  J M Fellick; J A Sills; O Marzouk; C A Hart; R W Cooke; A P Thomson
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

6.  Severity of meningococcal infections is related to anthropometrical parameters.

Authors:  N Perez; L Regairaz; J Bustamante; N Osimani; D Bergna; J Morales; M R Agosti; S Gonzalez-Ayala; C Peltzer; A Rodrigo
Journal:  Arch Dis Child       Date:  2007-05-08       Impact factor: 3.791

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.